See more : Alcor Micro,Corp. (8054.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of AdaptHealth Corp. (AHCO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AdaptHealth Corp., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- PT Bhuwanatala Indah Permai Tbk (BIPP.JK) Income Statement Analysis – Financial Results
- ForU Holdings, Inc. (FORU) Income Statement Analysis – Financial Results
- Lundin Mining Corporation (LUNMF) Income Statement Analysis – Financial Results
- Arrowhead Pharmaceuticals, Inc. (ARWR) Income Statement Analysis – Financial Results
- PT Bank JTrust Indonesia Tbk (BCIC.JK) Income Statement Analysis – Financial Results
AdaptHealth Corp. (AHCO)
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.20B | 2.97B | 2.45B | 1.06B | 529.64M | 345.28M | 192.56M | 174.32M |
| Cost of Revenue | 2.72B | 2.55B | 2.01B | 895.16M | 439.85M | 285.20M | 162.90M | 158.69M |
| Gross Profit | 479.56M | 417.43M | 445.61M | 161.23M | 89.80M | 60.08M | 29.66M | 15.63M |
| Gross Profit Ratio | 14.99% | 14.05% | 18.15% | 15.26% | 16.95% | 17.40% | 15.40% | 8.96% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 310.00K | 0.00 |
| General & Administrative | 190.09M | 162.13M | 167.51M | 89.35M | 56.49M | 1.04M | 9.00M | 8.00M |
| Selling & Marketing | 0.00 | 19.20M | 18.50M | 5.30M | -12.13M | 1.79M | 482.74K | 399.23K |
| SG&A | 190.09M | 162.13M | 167.51M | 89.35M | 44.36M | 1.04M | 693.00 | 11.40M |
| Other Expenses | 887.87M | 64.89M | 52.50M | -2.90M | 135.00K | 197.59K | 0.00 | 0.00 |
| Operating Expenses | 1.16B | 227.02M | 220.01M | 86.44M | 44.36M | 1.23M | 693.00 | 13.30M |
| Cost & Expenses | 3.80B | 2.78B | 2.23B | 981.60M | 157.70M | 1.23M | 693.00 | 171.99M |
| Interest Income | 0.00 | 109.41M | 95.20M | 41.43M | 39.30M | 4.15M | 0.00 | 5.76M |
| Interest Expense | 130.30M | 109.41M | 95.20M | 41.43M | 13.26M | 4.15M | 0.00 | 0.00 |
| Depreciation & Amortization | 420.59M | 423.44M | 333.18M | 82.45M | 62.57M | 50.61M | 27.82M | 26.56M |
| EBITDA | -171.09M | 630.76M | 483.66M | -82.17M | 110.30M | 80.85M | 43.90M | 28.89M |
| EBITDA Ratio | -5.35% | 18.22% | 19.63% | -1.19% | 7.00% | -0.36% | 0.00% | 16.57% |
| Operating Income | -598.40M | 190.41M | 225.61M | 74.79M | 29.70M | -1.23M | -690.00 | 2.32M |
| Operating Income Ratio | -18.70% | 6.41% | 9.19% | 7.08% | 5.61% | -0.36% | 0.00% | 1.33% |
| Total Other Income/Expenses | -125.38M | -92.51M | -34.65M | -277.39M | -51.24M | -8.85M | 0.00 | -5.76M |
| Income Before Tax | -723.78M | 97.90M | 190.96M | -70.67M | 12.53M | 2.92M | -693.00 | -3.44M |
| Income Before Tax Ratio | -22.62% | 3.30% | 7.78% | -6.69% | 2.37% | 0.84% | 0.00% | -1.97% |
| Income Tax Expense | -49.00M | 24.77M | 32.81M | -11.96M | 294.00K | 829.81K | 248.81K | 208.45K |
| Net Income | -678.90M | 69.32M | 156.18M | -58.72M | 12.24M | 2.09M | -693.00 | -3.79M |
| Net Income Ratio | -21.21% | 2.33% | 6.36% | -5.56% | 2.31% | 0.60% | 0.00% | -2.18% |
| EPS | -5.32 | 0.52 | 1.12 | -1.12 | 0.54 | 0.07 | 0.00 | -0.12 |
| EPS Diluted | -5.31 | 0.50 | 0.67 | -1.12 | 0.54 | 0.07 | 0.00 | -0.12 |
| Weighted Avg Shares Out | 134.16M | 134.18M | 133.03M | 52.48M | 22.46M | 31.25M | 31.25M | 31.25M |
| Weighted Avg Shares Out (Dil) | 134.42M | 138.99M | 133.03M | 52.49M | 22.56M | 31.25M | 31.25M | 31.25M |
Deadline Approaching for Receiving Share of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (AHCO) Recovery - Contact Levi & Korsinsky, LLP for Further Details
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (NASDAQ: AHCO). The settlement provides...
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) on Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ: AHCO). The settlement provides for a fund of $51,000,000...
AdaptHealth Corp. (AHCO) Shareholders - L&K, LLP Encourages you to File a Claim Against the Settlement Fund Before Deadline
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ:AHCO). The settlement provides for a fund of $51,000,000 to...
Deadline Approaching for Receiving Share of AdaptHealth Corp. (AHCO) Recovery - Contact Levi & Korsinsky, LLP for Further Details
NEW YORK, NY / ACCESSWIRE / June 20, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ:AHCO). The settlement provides for a fund of $51,000,000 to...
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) on Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / June 18, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ:AHCO). The settlement provides for a fund of $51,000,000 to...
Levi & Korsinsky, LLP Announces $51,000,000 Recovery for AdaptHealth Corp. (AHCO). File Your Claim Before Deadline
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ:AHCO). The settlement provides for a fund of $51,000,000 to...
The Portnoy Law Firm Announces Investigation of AdaptHealth Corp. (NASDAQ: AHCO)
Investors can contact the law firm at no cost to learn more about recovering their losses.
The Portnoy Law Firm Announces Investigation of AdaptHealth Corp. (NASDAQ: AHCO)
Investors can contact the law firm at no cost to learn more about recovering their losses.
Time Sensitive - Reminder from Levi & Korsinsky, LLP to File Claim for Share of AdaptHealth Corp. (AHCO) Settlement Fund Before Deadline
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ: AHCO). The settlement provides for a fund of $51,000,000...
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) on Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. (NASDAQ:AHCO). The settlement provides for a fund of $51,000,000 to...
Source: https://incomestatements.info
Category: Stock Reports